Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating ...

Guardant Health (NASDAQ:GH), a $5.49 billion market cap healthcare company, announced a significant step in its financial strategy, reaching an agreement to exchange a portion of its convertible notes ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on February 6, 2025, it ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results ...

Craig-Hallum analyst William Bonello maintained a Buy rating on Guardant Health (GH – Research Report) today. The company’s shares closed ...

Guardant Health had a negative net margin of 74.02% and a negative return on equity of 1,200.44%. The company’s revenue for the quarter was up 33.9% compared to the same quarter last year.

SG Americas Securities LLC decreased its position in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 43.1% during the 4th ...

Guardant Health (GH) announced an agreement with the Abu Dhabi Public Health Center ADPHC to introduce a non-invasive blood-based screening ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced an agreement with the Abu Dhabi ...